For the time in Pakistan, a coronavirus patient has recovered following a successful convalescent plasma therapy at a hospital in Karachi, a senior health expert said on Sunday.
Convalescent plasma therapy uses antibodies from the blood of a recovered coronavirus patient to treat those critically affected by the virus.
A 53-year-old COVID-19 patient admitted at Liaquat Medical University in Karachi was given convalescent plasma therapy last week.
The patient recovered after seven days, even before the usual two-week period, following the treatment, Dr Tahir Shamsi, head of the National Institute of Blood Diseases (NIBD), told reporters.
"I can confirm that the first coronavirus patient, treated with passive immunisation of plasma therapy, has recovered and has been discharged from the hospital," he said, without revealing the identity of the person.
Sindh, which is among the worst-hit provinces in Pakistan, has allowed the use of plasma therapy to treat COVID-19 patients.
Also known as passive immunisation, the therapy is still in an experimental stage for coronavirus treatment, but is being used in many countries, including India, China and the US.
Pakistan has reported 29,465 coronavirus cases and 637 fatalities. Punjab registered 11,093 cases, Sindh 10,771, Khyber-Pakhtunkhwa 4,509, Balochistan 1,935, Islamabad 641, Gilgit-Baltistan 430 and Pakistan-occupied Kashmir 86.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
